n(g),n(g')-dimethyl-l-arginine has been researched along with Fatty Liver in 8 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BET supplementation may be effective in preventing hyperlipidemia, disturbed NO availability, oxidative stress, and the development of fatty liver and atherosclerotic lesions that might result from excess amounts of cholesterol and methionine in the diet." | 7.88 | Effects of betaine supplementation on nitric oxide metabolism, atherosclerotic parameters, and fatty liver in guinea pigs fed a high cholesterol plus methionine diet. ( Bekpınar, S; Çevik, A; Genc, S; Gürdöl, F; Küskü-Kiraz, Z; Olgaç, V; Ünlücerci, Y; Uysal, M, 2018) |
| "Although impaired synthesis and/or bioavailability of nitric oxide are considered to contribute to insulin resistance and the progression of liver disease in nonalcoholic fatty liver disease, role of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, has not been examined." | 7.80 | Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. ( Chayama, K; Fukami, K; Hyogo, H; Ishitobi, T; Kimura, Y; Maeda, S; Nakahara, T; Okuda, S; Ueda, S; Yamagishi, S, 2014) |
| "Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease." | 5.38 | Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? ( Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S, 2012) |
| "BET supplementation may be effective in preventing hyperlipidemia, disturbed NO availability, oxidative stress, and the development of fatty liver and atherosclerotic lesions that might result from excess amounts of cholesterol and methionine in the diet." | 3.88 | Effects of betaine supplementation on nitric oxide metabolism, atherosclerotic parameters, and fatty liver in guinea pigs fed a high cholesterol plus methionine diet. ( Bekpınar, S; Çevik, A; Genc, S; Gürdöl, F; Küskü-Kiraz, Z; Olgaç, V; Ünlücerci, Y; Uysal, M, 2018) |
| "Although impaired synthesis and/or bioavailability of nitric oxide are considered to contribute to insulin resistance and the progression of liver disease in nonalcoholic fatty liver disease, role of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, has not been examined." | 3.80 | Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. ( Chayama, K; Fukami, K; Hyogo, H; Ishitobi, T; Kimura, Y; Maeda, S; Nakahara, T; Okuda, S; Ueda, S; Yamagishi, S, 2014) |
| "Our data suggested that NAFLD is associated with endothelial dysfunction and increased earlier in patients with atherosclerosis compared to control subjects." | 1.39 | Assessment of endothelial function in patients with nonalcoholic fatty liver disease. ( Colak, Y; Coskunpinar, E; Doganay, L; Kahraman, OT; Mesci, B; Ozturk, O; Senates, E; Tuncer, I; Ulasoglu, C; Yesil, A; Yilmaz, Y, 2013) |
| "Nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of metabolic syndrome (MetS) is closely associated with an increased risk of cardiovascular disease." | 1.39 | Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. ( Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Karslioglu, Y; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S, 2013) |
| "Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease." | 1.38 | Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? ( Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Küskü-Kiraz, Z | 1 |
| Genc, S | 1 |
| Bekpınar, S | 1 |
| Ünlücerci, Y | 1 |
| Çevik, A | 1 |
| Olgaç, V | 1 |
| Gürdöl, F | 1 |
| Uysal, M | 1 |
| Di Pasqua, LG | 1 |
| Berardo, C | 1 |
| Rizzo, V | 1 |
| Richelmi, P | 1 |
| Croce, AC | 1 |
| Vairetti, M | 1 |
| Ferrigno, A | 1 |
| Karakurt, F | 1 |
| Carlioglu, A | 1 |
| Koktener, A | 1 |
| Ozbek, M | 1 |
| Kaya, A | 1 |
| Uyar, ME | 1 |
| Kasapoglu, B | 1 |
| Ilhan, A | 1 |
| Kasumov, T | 1 |
| Edmison, JM | 1 |
| Dasarathy, S | 1 |
| Bennett, C | 1 |
| Lopez, R | 1 |
| Kalhan, SC | 1 |
| Dogru, T | 2 |
| Genc, H | 2 |
| Tapan, S | 2 |
| Ercin, CN | 2 |
| Ors, F | 2 |
| Aslan, F | 2 |
| Kara, M | 2 |
| Sertoglu, E | 2 |
| Bagci, S | 2 |
| Kurt, I | 2 |
| Sonmez, A | 2 |
| Colak, Y | 1 |
| Senates, E | 1 |
| Yesil, A | 1 |
| Yilmaz, Y | 1 |
| Ozturk, O | 1 |
| Doganay, L | 1 |
| Coskunpinar, E | 1 |
| Kahraman, OT | 1 |
| Mesci, B | 1 |
| Ulasoglu, C | 1 |
| Tuncer, I | 1 |
| Karslioglu, Y | 1 |
| Hyogo, H | 1 |
| Yamagishi, S | 1 |
| Maeda, S | 1 |
| Fukami, K | 1 |
| Ueda, S | 1 |
| Okuda, S | 1 |
| Nakahara, T | 1 |
| Kimura, Y | 1 |
| Ishitobi, T | 1 |
| Chayama, K | 1 |
8 other studies available for n(g),n(g')-dimethyl-l-arginine and Fatty Liver
| Article | Year |
|---|---|
Effects of betaine supplementation on nitric oxide metabolism, atherosclerotic parameters, and fatty liver in guinea pigs fed a high cholesterol plus methionine diet.
Topics: Animals; Arginine; Atherosclerosis; Betaine; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; Diet | 2018 |
MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters.
Topics: Amino Acid Transport Systems, Basic; Animals; Arginine; Choline; Disease Models, Animal; Fatty Liver | 2016 |
Relationship between cerebral arterial pulsatility and carotid intima media thickness in diabetic and non-diabetic patients with non-alcoholic fatty liver disease.
Topics: Aged; Arginine; Basilar Artery; Carotid Arteries; Diabetes Mellitus, Type 2; Fatty Liver; Female; Hu | 2009 |
Plasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.
Topics: Adult; Arginine; Biopsy; Blood Glucose; Chromatography, High Pressure Liquid; Fatty Liver; Female; G | 2011 |
Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
Topics: Adult; Arginine; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Fatty Liver; H | 2012 |
Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
Topics: Adult; Arginine; Atherosclerosis; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; | 2013 |
Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Topics: Adiponectin; Adult; alpha-2-HS-Glycoprotein; Arginine; Atherosclerosis; Carotid Artery Diseases; Car | 2013 |
Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients.
Topics: Adult; Aged; Arginine; Fatty Liver; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Dis | 2014 |